XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3
SEGMENT REPORTING (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Total assets $ 71,525,379   $ 71,525,379   $ 68,038,621
Segment profit / (loss) (4,254,902)   (5,726,644)    
Revenue 12,823,797 $ 12,016,098 37,537,003 $ 38,296,402  
Pharma manufacturing [Member]          
Total assets 11,892,278   11,892,278   12,624,313
Segment profit / (loss) (604,790)   (604,790)    
Revenue 91,055   91,055    
Other [Member]          
Total assets 6,077,698   6,077,698   35,272,337
Segment profit / (loss) (1,082,184)   (1,177,414)    
Wholesale [Member]          
Total assets 23,728,729   23,728,729   23,605,372
Segment profit / (loss) (728,986)   (549,841)    
Revenue 11,936,166   34,908,505    
Nutraceuticals and Pharmaceuticals [Member]          
Total assets 29,950,031   29,950,031   $ 32,057,782
Segment profit / (loss) (1,838,942)   (2,944,599)    
Revenue $ 796,576   $ 2,537,443